Hanson McClain Advisors »

Lyell Immunopharma shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $863 43 20.07

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Lyell Immunopharma

Arch Venture Corp
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Susquehanna International
Alphabet
BlackRock
Geode Capital Management
Sc China Holding
Marshall Wace

View all funds holding Lyell Immunopharma